Chinanews.com, November 22. On November 21, the relevant person in charge of the Shanghai Stock Exchange answered questions from reporters.
A reporter asked: Recently, some self-media reported on the listing of companies on the Science and Technology Innovation Board, focusing on their business and income involving nucleic acid testing.
What is the SSE's comment on this?
The relevant person in charge of the Shanghai Stock Exchange said that we have noticed relevant reports.
We pay close attention to the listing applications of nucleic acid testing companies and insist on strict review, especially the scientific and technological innovation attributes and sustainable operation capabilities of the companies.
According to the issuance and listing conditions and review standards of the Science and Technology Innovation Board, the company’s application for issuance and listing was carefully reviewed, focusing on its attributes of science and technology innovation, the relevance of nucleic acid testing-related businesses to the main business, the sustainability of related income, and the elimination of Whether the company still meets the conditions for issuance and listing after such business income requires the company to disclose risks.
The SSE will continue to conscientiously implement the decisions and arrangements of the Party Central Committee and the State Council and the work requirements of the CSRC, adhere to the positioning of the Science and Technology Innovation Board, strictly control market access, and prudently promote the issuance and listing of relevant enterprises.
We welcome comments and suggestions from all parties in the market.
On the same day, the spokesperson of the Shenzhen Stock Exchange answered questions from reporters.
A reporter asked: Recently, some self-media reported on the application of Daktronics and other companies to go public on the GEM, focusing on the nucleic acid testing involved in their business and income.
What is the Shenzhen Stock Exchange's comment on this?
A spokesperson for the Shenzhen Stock Exchange said that we have noticed relevant reports.
We pay close attention to the listing applications of companies involved in nucleic acid testing, and insist on strict review, especially the sustainable operation capabilities of companies.
According to the issuance and listing conditions and review standards of the GEM, the applications of relevant companies were carefully reviewed, focusing on the relevance of their nucleic acid testing-related businesses to their main business, the sustainability of related income, and after excluding such business income Whether the company still meets the conditions for issuance and listing, etc., the company is required to make full disclosure.
The Shenzhen Stock Exchange will continue to earnestly implement the decisions and deployments of the Party Central Committee and the State Council and the work requirements of the China Securities Regulatory Commission, adhere to the positioning of the ChiNext Board, strictly control market access, and prudently promote the issuance and listing of relevant companies.
We welcome comments and suggestions from all parties in the market.
(China New Finance and Economics)